ro glp 1 supply tracker launches GLP-1 to help patients navigate shortages Ro CEO Zach Reitano talks

Injectables: GLP-1 and GIP/GLP-1 RAs versus basal insulin Randomised controlled trials (RTCs) have demonstrated that both semaglutide (Aroda et al, 2017) and tirzepatide (Ludvik et al, 2021

Neck fans

Chronic intestinal pseudo-obstruction: manifestations, natural history and management

These effects make GLP-1RAs a suitable choice for treating binge eating disorder and bulimia nervosa

The first-line approach involves ensuring adequate hydration, as GLP-1 receptor agonists can reduce fluid intake through appetite suppression and may cause mild dehydration, particularly if accompanied by nausea or vomiting

Weight-loss outcomes supported by peer-reviewed clinical data Naturally helps curb appetite and minimize unnecessary snacking Encourages a more efficient metabolism and consistent daily energy Supports healthier insulin function and more stable blood-sugar patterns Promotes lasting fullness to help reduce overeating GLP-1s work with your body's natural biology to support meaningful, sustainable weight loss